Improving guideline-based care for lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study helps doctors improve how they follow lung cancer treatment guidelines. If you join, your care and outcomes will be tracked to see if following guidelines leads to better results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer (NSCLC) or extensive-stage small cell lung cancer (ES-SCLC).
- You have not yet started treatment for this cancer, OR you have finished certain earlier treatments (like chemotherapy or radiation) at least 12 months ago and the cancer has not come back.
- You are able to take care of yourself (performance status 0-2).
- Your doctor expects you to live longer than 12 weeks.
- You are not planning to switch to another hospital for your treatment within the next 3 months.
- You are not participating in another interventional clinical study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This study follows adults with confirmed lung cancer as they are diagnosed and treated in routine clinical practice. It aims to better understand how lung cancer is diagnosed and managed day-to-day, which may help improve future care.
This study collects real-world information about people with lung cancer who get newer kinds of cancer drugs. It aims to understand how these innovative therapies work in everyday care and help future research.
This is an observational study of people with lung cancer. The goal is to better understand care patterns and outcomes; joining would involve giving consent and answering study questions.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This trial tests a quality-of-life support program meant to help people with early-stage lung cancer think through their treatment choices. It may help you feel more informed and more confident about deciding between treatments like surgery and SBRT.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.